Andere talen Carmell Corporation

Aandelen

CTCX

US1429221039

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,4 ^USD	+4,35%		+10,60%	-37,01%

01/04	Carmell Corporation meldt resultaten voor het op 31 december 2023 afgesloten boekjaar	CI
26/03	Een niet nader genoemde koper heeft de overname afgerond van Axolotl Biologix, Inc. van Carmell Corporation (NasdaqCM:CTCX).	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Carmell Announces Successful Closing of $3.0 Million Private Placement	11/04
Carmell Corporation announced that it has received $3 million in funding	11/04
Carmell Announces $3.0 Million Private Placement	04/04
Carmell Corporation announced that it expects to receive $3 million in funding	04/04
Carmell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction	27/03
An undisclosed buyer completed the acquisition of Axolotl Biologix, Inc. from Carmell Corporation.	26/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook	21/03
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket	21/03
An undisclosed buyer entered into a a definitive agreement to acquire Axolotl Biologix, Inc. from Carmell Corporation ).	20/03
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02
Carmell Corporation Announces Appointment of Dr. Bradley Calobrace to Scientific Advisory Board	17/01
Carmell Corp Announces Appointment of Dr. Jason D. Bloom to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Adam Rubinstein to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Gregory A. Buford to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Sean Kelishadi to Scientific Advisory Board	17/01
Carmell Corporation Announces Addition of Two Independent Directors	16/11
Carmell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Carmell Therapeutics Corporation(NasdaqCM:CTCX) added to S&P TMI Index	18-09-23
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine	12-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Carmell Corporation

Aandelen

CTCX

US1429221039

Andere talen

Filters